Topos Bio
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1517 N Point St 445 A, San Francisco, Ca...Website
www.toposbio.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Topos Bio
Topos Bio is focused on redefining drug discovery by targeting intrinsically disordered proteins (IDPs), which are crucial in various diseases but challenging to address with traditional methods. The company integrates AI with biophysics and computational chemistry to develop a proprietary discovery engine that models the dynamic conformational landscapes of IDPs. Their platform supports the design of therapeutics, particularly small molecules, peptides, and targeted degraders, aimed at modulating disordered regions and protein-protein interactions. Topos Bio seeks partners interested in collaborative opportunities in molecular design and AI-driven drug discovery.Explore more
Topos Bio Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Topos Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Topos Bio recently announced quarterly report
Check if Topos Bio has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Topos Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Topos Bio has new funding data
Product Launch: Get notified when Topos Bio launches new products
Click to see if Topos Bio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Topos Bio
Website visits: Recent activity has been detected on your website
Check out if Topos Bio is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Topos Bio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Topos Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Topos Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Topos Bio.
Topos Bio financials insights
Gather financial insights about Topos Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Seed
$10.5M
Topos Bio Tech Stack
A closer look at the technologies used by Topos Bio
See more technologies
Topos Bio News & Media
Topos Bio Raises $10.5M Seed to Target 'Undruggable' Proteins in Alzheimer's and Cancer
Topos Bio has emerged from stealth with $10.5 million in seed financing to advance a new approach to drug discovery focused on intrinsically disordered proteins, a class of biological targets long considered inaccessible to conventional therapeutics. The funding round was led by Boldstart, Threshold, and Neo, with participation from angel investors including Dara Khosrowshahi and Naveen Rao.Intrinsically disordered proteins differ fundamentally from the structured proteins that underpin most modEx-Intel AI CTO Launches Topos Bio with $10.5M to Tackle 'Undruggable' Proteins Driving ...
For decades, the pharmaceutical industry has operated on a singular, rigid principle: the "lock-and-key" model. If a protein is the lock driving a disease
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Topos Bio
Sign Up For FreeTo access detailed company insights
Topos Bio is focused on redefining drug discovery by targeting intrinsically disordered proteins (IDPs), which are crucial in various diseases but challenging to address with traditional methods. The company integrates AI with biophysics and computational chemistry to develop a proprietary discovery engine that models the dynamic conformational lan... Read More
